Does the media favor IRTC or BAX?

In the previous week, Baxter International had 21 more articles in the media than iRhythm Technologies. MarketBeat recorded 27 mentions for Baxter International and 6 mentions for iRhythm Technologies. Baxter International's average media sentiment score of 0.94 beat iRhythm Technologies' score of 0.28 indicating that Baxter International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Baxter International 13 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IRTC or PEN?

In the previous week, Penumbra had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 8 mentions for Penumbra and 6 mentions for iRhythm Technologies. Penumbra's average media sentiment score of 1.51 beat iRhythm Technologies' score of 0.28 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Penumbra 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher valuation and earnings, IRTC or SNN?

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRhythm Technologies $747.14M 5.67 -$44.55M -$0.43 N/A Smith & Nephew SNATS $6.16B 2.00 $625M N/A N/A

Does the media favor IRTC or SNN?

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Smith & Nephew SNATS and 6 mentions for iRhythm Technologies. Smith & Nephew SNATS's average media sentiment score of 0.52 beat iRhythm Technologies' score of 0.28 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Smith & Nephew SNATS 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IRTC or GMED?

In the previous week, Globus Medical had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 7 mentions for Globus Medical and 6 mentions for iRhythm Technologies. Globus Medical's average media sentiment score of 0.71 beat iRhythm Technologies' score of 0.28 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Globus Medical 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer IRTC or GKOS?

In the previous week, Glaukos had 21 more articles in the media than iRhythm Technologies. MarketBeat recorded 27 mentions for Glaukos and 6 mentions for iRhythm Technologies. Glaukos' average media sentiment score of 0.81 beat iRhythm Technologies' score of 0.28 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Glaukos 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

iRhythm Technologies (IRTC) Competitors

$128.52 +0.54 (+0.42%)

As of 08/21/2026 04:00 PM Eastern

Compare

IRTC vs. BAX, PEN, SNN, GMED, and GKOS

Should you buy iRhythm Technologies stock or one of its competitors? iRhythm Technologies's main competitors and comparable companies include Baxter International (BAX), Penumbra (PEN), Smith & Nephew SNATS (SNN), Globus Medical (GMED), and Glaukos (GKOS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does iRhythm Technologies compare to Baxter International?

iRhythm Technologies (NASDAQ:IRTC) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

iRhythm Technologies has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Baxter International has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

iRhythm Technologies has a net margin of -1.69% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Baxter International	-9.27%	16.57%	5.24%

In the previous week, Baxter International had 21 more articles in the media than iRhythm Technologies. MarketBeat recorded 27 mentions for Baxter International and 6 mentions for iRhythm Technologies. Baxter International's average media sentiment score of 0.94 beat iRhythm Technologies' score of 0.28 indicating that Baxter International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Baxter International	13 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

90.2% of Baxter International shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

iRhythm Technologies has higher earnings, but lower revenue than Baxter International. iRhythm Technologies is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.67	-$44.55M	-$0.43	N/A
Baxter International	$11.24B	1.21	-$957M	-$2.07	N/A

iRhythm Technologies currently has a consensus price target of $179.93, suggesting a potential upside of 40.00%. Baxter International has a consensus price target of $22.45, suggesting a potential downside of 14.85%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

iRhythm Technologies beats Baxter International on 10 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Penumbra?

iRhythm Technologies (NASDAQ:IRTC) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

88.9% of Penumbra shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

iRhythm Technologies has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

iRhythm Technologies presently has a consensus target price of $179.93, suggesting a potential upside of 40.00%. Penumbra has a consensus target price of $367.07, suggesting a potential upside of 12.90%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Penumbra	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12

Penumbra has a net margin of 10.67% compared to iRhythm Technologies' net margin of -1.69%. Penumbra's return on equity of 10.50% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Penumbra	10.67%	10.50%	8.17%

In the previous week, Penumbra had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 8 mentions for Penumbra and 6 mentions for iRhythm Technologies. Penumbra's average media sentiment score of 1.51 beat iRhythm Technologies' score of 0.28 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Penumbra	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Penumbra has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.67	-$44.55M	-$0.43	N/A
Penumbra	$1.40B	9.12	$177.69M	$4.07	79.89

Summary

Penumbra beats iRhythm Technologies on 12 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Smith & Nephew SNATS?

iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

iRhythm Technologies presently has a consensus target price of $179.93, indicating a potential upside of 40.00%. Smith & Nephew SNATS has a consensus target price of $30.93, indicating a potential upside of 5.58%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Smith & Nephew SNATS	2 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -1.69%. iRhythm Technologies' return on equity of 10.11% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Smith & Nephew SNATS	N/A	N/A	N/A

In the previous week, Smith & Nephew SNATS had 3 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Smith & Nephew SNATS and 6 mentions for iRhythm Technologies. Smith & Nephew SNATS's average media sentiment score of 0.52 beat iRhythm Technologies' score of 0.28 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smith & Nephew SNATS	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market.

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.67	-$44.55M	-$0.43	N/A
Smith & Nephew SNATS	$6.16B	2.00	$625M	N/A	N/A

Summary

iRhythm Technologies beats Smith & Nephew SNATS on 8 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Globus Medical?

iRhythm Technologies (NASDAQ:IRTC) and Globus Medical (NYSE:GMED) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

iRhythm Technologies currently has a consensus price target of $179.93, suggesting a potential upside of 40.00%. Globus Medical has a consensus price target of $101.77, suggesting a potential upside of 17.23%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe iRhythm Technologies is more favorable than Globus Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Globus Medical has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.67	-$44.55M	-$0.43	N/A
Globus Medical	$3.14B	3.71	$537.87M	$3.91	22.20

iRhythm Technologies has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market.

In the previous week, Globus Medical had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 7 mentions for Globus Medical and 6 mentions for iRhythm Technologies. Globus Medical's average media sentiment score of 0.71 beat iRhythm Technologies' score of 0.28 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Globus Medical	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Globus Medical has a net margin of 17.02% compared to iRhythm Technologies' net margin of -1.69%. Globus Medical's return on equity of 14.57% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Globus Medical	17.02%	14.57%	12.62%

95.2% of Globus Medical shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Globus Medical beats iRhythm Technologies on 12 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Glaukos?

iRhythm Technologies (NASDAQ:IRTC) and Glaukos (NYSE:GKOS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

In the previous week, Glaukos had 21 more articles in the media than iRhythm Technologies. MarketBeat recorded 27 mentions for Glaukos and 6 mentions for iRhythm Technologies. Glaukos' average media sentiment score of 0.81 beat iRhythm Technologies' score of 0.28 indicating that Glaukos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Glaukos	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has a net margin of -1.69% compared to Glaukos' net margin of -30.68%. iRhythm Technologies' return on equity of 10.11% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Glaukos	-30.68%	-6.37%	-4.78%

iRhythm Technologies has higher revenue and earnings than Glaukos. iRhythm Technologies is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.67	-$44.55M	-$0.43	N/A
Glaukos	$507.44M	21.58	-$187.69M	-$3.25	N/A

iRhythm Technologies currently has a consensus price target of $179.93, indicating a potential upside of 40.00%. Glaukos has a consensus price target of $178.08, indicating a potential downside of 4.08%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Glaukos	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79

99.0% of Glaukos shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 5.9% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

iRhythm Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Glaukos has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Summary

iRhythm Technologies beats Glaukos on 10 of the 16 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRTC vs. The Competition

Export

Metric	iRhythm Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.24B	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.75%	2.53%	11.08%
P/E Ratio	-298.88	26.67	272.60	24.24
Price / Sales	5.67	45.38	618.96	99.78
Price / Cash	N/A	33.24	78.62	53.99
Price / Book	22.79	6.23	13.05	6.20
Net Income	-$44.55M	$150.07M	$3.47B	$348.59M
7 Day Performance	1.65%	0.69%	2.09%	0.08%
1 Month Performance	19.36%	8.91%	6.64%	3.88%
1 Year Performance	-24.01%	8.07%	25.02%	16.98%

iRhythm Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRTC iRhythm Technologies	3.9434 of 5 stars	$128.52 +0.4%	$179.93 +40.0%	-24.0%	$4.24B	$747.14M	N/A	2,400	Analyst Forecast
BAX Baxter International	1.7446 of 5 stars	$26.67 -1.4%	$22.45 -15.8%	+7.7%	$13.98B	$11.24B	N/A	37,500	News Coverage Analyst Revision
PEN Penumbra	3.7202 of 5 stars	$326.91 +0.0%	$367.07 +12.3%	+22.8%	$12.87B	$1.40B	80.32	4,700	Positive News
SNN Smith & Nephew SNATS	2.2885 of 5 stars	$29.84 -0.9%	$30.93 +3.7%	-22.0%	$12.72B	$6.16B	N/A	16,988	News Coverage
GMED Globus Medical	3.8037 of 5 stars	$85.75 -0.2%	$101.77 +18.7%	+38.8%	$11.54B	$2.94B	21.93	6,000	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRTC) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Competitors

IRTC vs. BAX, PEN, SNN, GMED, and GKOS

How does iRhythm Technologies compare to Baxter International?

Summary

How does iRhythm Technologies compare to Penumbra?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Summary

How does iRhythm Technologies compare to Globus Medical?

Summary

How does iRhythm Technologies compare to Glaukos?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Competitors

IRTC vs. BAX, PEN, SNN, GMED, and GKOS

How does iRhythm Technologies compare to Baxter International?

Which has more risk and volatility, IRTC or BAX?

Is IRTC or BAX more profitable?

Does the media favor IRTC or BAX?

Do institutionals and insiders hold more shares of IRTC or BAX?

Which has preferable earnings and valuation, IRTC or BAX?

Do analysts prefer IRTC or BAX?

Summary

How does iRhythm Technologies compare to Penumbra?

Do insiders and institutionals hold more shares of IRTC or PEN?

Which has more risk & volatility, IRTC or PEN?

Do analysts prefer IRTC or PEN?

Is IRTC or PEN more profitable?

Does the media favor IRTC or PEN?

Which has stronger valuation and earnings, IRTC or PEN?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Do institutionals and insiders believe in IRTC or SNN?

Do analysts prefer IRTC or SNN?

Is IRTC or SNN more profitable?

Does the media favor IRTC or SNN?

Which has more risk and volatility, IRTC or SNN?

Which has higher valuation and earnings, IRTC or SNN?

Summary

How does iRhythm Technologies compare to Globus Medical?

Do analysts recommend IRTC or GMED?

Which has stronger earnings and valuation, IRTC or GMED?

Which has more volatility and risk, IRTC or GMED?

Does the media favor IRTC or GMED?

Is IRTC or GMED more profitable?

Do institutionals and insiders hold more shares of IRTC or GMED?

Summary

How does iRhythm Technologies compare to Glaukos?

Does the media prefer IRTC or GKOS?

Is IRTC or GKOS more profitable?

Which has higher valuation and earnings, IRTC or GKOS?

Do analysts prefer IRTC or GKOS?

Do institutionals & insiders believe in IRTC or GKOS?

Which has more volatility & risk, IRTC or GKOS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools